NABRIVA THERAPEUTICS PLC ORDINARY SHARES, $0.01 NOMINAL VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • September 20th, 2017 • Nabriva Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledSeptember 20th, 2017 Company Industry JurisdictionAddress for Notices to the Company: 1000 Continental Drive, Suite 600 King of Prussia, PA 19406 Facsimile: (610) 816-6639 Attention: Gary Sender, Chief Financial Officer